Works by Jauw, Yvonne W. S.

Results: 15

89Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568

By:

Jauw, Yvonne W. S.;
O’Donoghue, Joseph A.;
Zijlstra, Josée M.;
Hoekstra, Otto S.;
Willemien Menke-van der Houven van Oordt, C.;
Morschhauser, Franck;
Carrasquillo, Jorge A.;
Zweegman, Sonja;
Taskar, Neeta Pandit-;
Lammertsma, Adriaan A.;
van Dongen, Guus. A. M. S.;
Boellaard, Ronald;
Weber, Wolfgang A.;
Huisman, Marc C.

Publication type:

Article

Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients.

Published in:

Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1828, doi. 10.2967/jnumed.109.065862

By:

Börjesson, Pontus K. E.;
Jauw, Yvonne W. S.;
de Bree, Remco;
Roos, Jan C.;
Castelijns, Jonas A.;
Leemans, C. Réne;
van Dongen, Guus A. M. S.;
Boellaard, Ronald

Publication type:

Article

Blood‐based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti‐PD‐1 Treatment.

Published in:

HemaSphere, 2022, v. 6, n. 7, p. e749, doi. 10.1097/HS9.0000000000000749

By:

Drees, Esther E. E.;
Jauw, Yvonne W. S.;
van Dijk, Erik;
Borchmann, Sven;
Verkuijlen, Sandra A. W. M.;
Stathi, Phylicia;
Groenewegen, Nils J.;
Hijmering, Nathalie J.;
Berry, Daniella R. A. I.;
Meershoek, Eric J.;
Hoogmoed, Danielle;
Kwakman, Anne;
Molenaar, Tessa J.;
Pegtel, Dirk M.;
Ylstra, Bauke;
de Jong, Daphne;
Zijlstra, Josée M.;
Roemer, Margaretha G. M.

Publication type:

Article

Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Published in:

PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0169828

By:

Jauw, Yvonne W. S.;
Zijlstra, Josée M.;
de Jong, Daphne;
Vugts, Danielle J.;
Zweegman, Sonja;
Hoekstra, Otto S.;
van Dongen, Guus A. M. S.;
Huisman, Marc C.

Publication type:

Article

Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1

By:

Wijngaarden, Jessica E.;
Huisman, Marc C.;
Jauw, Yvonne W. S.;
van Dongen, Guus A. M. S.;
Greuter, Henri N. J. M.;
Schuit, Robert C.;
Cleveland, Matthew;
Gootjes, Elske C.;
Vugts, Daniëlle J.;
Menke-van der Houven van Oordt, C. Willemien;
Boellaard, Ronald

Publication type:

Article

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6

By:

Jauw, Yvonne W. S.;
Bensch, Frederike;
Brouwers, Adrienne H.;
Hoekstra, Otto S.;
Zijlstra, Josée M.;
Pieplenbosch, Simone;
Schröder, Carolien P.;
Zweegman, Sonja;
van Dongen, Guus A. M. S.;
Menke-van der Houven van Oordt, C. Willemien;
de Vries, Elisabeth G. E.;
de Vet, Henrica C. W.;
Boellaard, Ronald;
Huisman, Marc C.

Publication type:

Article

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.

Published in:

2018

By:

Jauw, Yvonne W. S.;
Heijtel, Dennis F.;
Zijlstra, Josée M.;
Hoekstra, Otto S.;
de Vet, Henrica C. W.;
Vugts, Danielle J.;
Verheul, Henk M.;
Boellaard, Ronald;
Zweegman, Sonja;
van Dongen, Guus A. M. S.;
der Houven van Oordt, C. Willemien Menke-van;
Lammertsma, Adriaan A.;
Huisman, Marc C.

Publication type:

journal article

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET.

Published in:

EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5

By:

Wijngaarden, Jessica E.;
Jauw, Yvonne W. S.;
Zwezerijnen, Gerben J. C.;
de Wit-van der Veen, Berlinda J.;
Vugts, Daniëlle J.;
Zijlstra, Josée M.;
van Dongen, Guus A. M. S.;
Boellaard, Ronald;
Menke-van der Houven van Oordt, C. Willemien;
Huisman, Marc C.

Publication type:

Article

Optimal imaging time points considering accuracy and precision of Patlak linearization for 89Zr-immuno-PET: a simulation study.

Published in:

EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00927-6

By:

Wijngaarden, Jessica E.;
Huisman, Marc C.;
Pouw, Johanna E. E.;
Menke-van der Houven van Oordt, C. Willemien;
Jauw, Yvonne W. S.;
Boellaard, Ronald

Publication type:

Article

Noise sensitivity of 89Zr-Immuno-PET radiomics based on count-reduced clinical images.

Published in:

EJNMMI Physics, 2022, v. 9, n. 1, p. 1, doi. 10.1186/s40658-022-00444-4

By:

Somasundaram, Ananthi;
García, David Vállez;
Pfaehler, Elisabeth;
Jauw, Yvonne W. S.;
Zijlstra, Josée M.;
van Dongen, Guus A. M. S.;
Menke-van der Houven van Oordt, Willemien C.;
Huisman, Marc C.;
de Vries, Elisabeth G. E.;
Boellaard, Ronald

Publication type:

Article

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40218-1

By:

Ferrández, Maria C.;
Golla, Sandeep S. V.;
Eertink, Jakoba J.;
de Vries, Bart M.;
Lugtenburg, Pieternella J.;
Wiegers, Sanne E.;
Zwezerijnen, Gerben J. C.;
Pieplenbosch, Simone;
Kurch, Lars;
Hüttmann, Andreas;
Hanoun, Christine;
Dührsen, Ulrich;
de Vet, Henrica C. W.;
PETRA;
Hoekstra, Otto S.;
Burggraaff, Coreline N.;
Bes, Annelies;
Heymans, Martijn W.;
Jauw, Yvonne W. S.;
Chamuleau, Martine E. D.

Publication type:

Article

Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example.

Published in:

EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00813-7

By:

Huisman, Marc C.;
Menke-van der Houven van Oordt, C. Willemien;
Zijlstra, Josée M.;
Hoekstra, Otto S.;
Boellaard, Ronald;
van Dongen, Guus A. M. S.;
Shah, Dhaval K.;
Jauw, Yvonne W. S.

Publication type:

Article

Feasibility of Using 18 F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung Disease.

Published in:

Diagnostics (2075-4418), 2024, v. 14, n. 22, p. 2531, doi. 10.3390/diagnostics14222531

By:

Smith, Charlotte L. C.;
Zwezerijnen, Gerben J. C.;
Wiegers, Sanne E.;
Jauw, Yvonne W. S.;
Lugtenburg, Pieternella J.;
Zijlstra, Josée M.;
Yaqub, Maqsood;
Boellaard, Ronald

Publication type:

Article

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.

Published in:

Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596

By:

de Vries, Bart M.;
Golla, Sandeep S. V.;
Zwezerijnen, Gerben J. C.;
Hoekstra, Otto S.;
Jauw, Yvonne W. S.;
Huisman, Marc C.;
van Dongen, Guus A. M. S.;
Menke-van der Houven van Oordt, Willemien C.;
Zijlstra-Baalbergen, Josée J. M.;
Mesotten, Liesbet;
Boellaard, Ronald;
Yaqub, Maqsood

Publication type:

Article

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.

Published in:

EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0358-8

By:

Jauw, Yvonne W. S.;
Huisman, Marc C.;
Nayak, Tapan K.;
Vugts, Danielle J.;
Christen, Randolph;
Naegelen, Valerie Meresse;
Ruettinger, Dominik;
Heil, Florian;
Lammertsma, Adriaan A.;
Verheul, Henk M. W.;
Hoekstra, Otto S.;
van Dongen, Guus A. M. S.;
Menke-van der Houven van Oordt, C. Willemien

Publication type:

Article

Works by Jauw, Yvonne W. S.

<sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.

Radiation Dosimetry of <sup>89</sup>Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients.

Blood‐based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti‐PD‐1 Treatment.

Performance of <sup>89</sup>Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.

Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.

Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images.

Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.

Optimal imaging time points considering accuracy and precision of Patlak linearization for <sup>89</sup>Zr-immuno-PET: a simulation study.

Noise sensitivity of <sup>89</sup>Zr-Immuno-PET radiomics based on count-reduced clinical images.

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients.

Potential and pitfalls of <sup>89</sup>Zr-immuno-PET to assess target status: <sup>89</sup>Zr-trastuzumab as an example.

Feasibility of Using 18 F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung Disease.

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.

Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibody.